Related Experiment Video
Updated: Feb 7, 2026

Preparation and In Vitro Characterization of Magnetized miR-modified Endothelial Cells
Published on: May 2, 2017
miR-27b Suppresses Endothelial Cell Proliferation and Migration by Targeting Smad7 in Kawasaki Disease
Xing Rong1, Donghui Ge1, Danping Shen1
1Children's Heart Center, the Second Affiliated Hospital and Yuying Children's Hospital, Institute of Cardiovascular Development and Translational Medicine, Wenzhou Medical University, Wenzhou, China.
Background/Aims:
Increasing evidence indicates that microRNAs (miRNAs) play important roles in Kawasaki disease (KD). Our previous study demonstrated that hsa-miR-27b-3p (miR-27b) was up-regulated in KD serum. However, the specific role of miR-27b in KD remains unclear. We aimed to investigate that miR-27b could be a biomarker and therapeutic target for KD treatment. As well, the specific mechanism of miR-27b effecting endothelial cell functions was studied.
Methods:
The expression of miR-27b and Smad7 was measured by qRT-PCR. Gain-of-function strategy was used to observe the effect of miR-27b on human umbilical vein endothelial cells (HUVECs) proliferation and migration. Bioinformatics analyses were applied to predict miR-27b targets and then we verified Smad7 by a luciferase reporter assay. Western blot was performed to detect the protein expression of Smad7, PCNA, MMP9, MMP12 and TGF-β-related genes.
Results:
We confirmed that miR-27b was shown to be dramatically up-regulated in KD serum and KD serum-treated HUVECs and that elevated expression of miR-27b suppressed the proliferation and migration of HUVECs. Furthermore, our results verified that miR-27b mediated cell functions by affecting the TGF-β via targeting Smad7 in HUVECs.
Conclusion:
These results suggested that up-regulated miR-27b had a protective role in HUVECs proliferation and migration via targeting Smad7 and affecting TGF-β pathway. Therefore, miR-27b represented a potential biomarker for KD and may serve as a promising therapeutic target for KD treatment.
Insights
MicroRNA-27b (miR-27b) is elevated in Kawasaki disease (KD) and protects endothelial cells by targeting Smad7, suggesting miR-27b as a potential KD biomarker and therapeutic target.
Area of Science:
- Molecular Biology
- Immunology
- Cardiovascular Research
Background:
- MicroRNAs (miRNAs) are increasingly recognized for their roles in Kawasaki disease (KD).
- Previous studies identified hsa-miR-27b-3p (miR-27b) as upregulated in KD serum.
- The precise function and mechanism of miR-27b in KD pathogenesis remained unclear.
Purpose of the Study:
- To investigate miR-27b as a potential biomarker and therapeutic target for KD.
- To elucidate the mechanism by which miR-27b influences endothelial cell function in KD.
Main Methods:
- Quantitative real-time PCR (qRT-PCR) to measure miR-27b and Smad7 expression.
- Gain-of-function experiments in human umbilical vein endothelial cells (HUVECs) to assess proliferation and migration.
- Bioinformatics analysis and luciferase reporter assays to identify and validate miR-27b targets.
- Western blotting to analyze protein expression related to cell function and TGF-β signaling.
Main Results:
- miR-27b was significantly upregulated in KD serum and HUVECs treated with KD serum.
- Elevated miR-27b expression inhibited HUVEC proliferation and migration.
- miR-27b was confirmed to target Smad7, mediating its effects on TGF-β signaling pathways in HUVECs.
Conclusions:
- Upregulated miR-27b exhibits a protective effect on endothelial cell proliferation and migration by targeting Smad7 and modulating the TGF-β pathway.
- miR-27b demonstrates potential as a diagnostic biomarker for KD.
- miR-27b represents a promising therapeutic target for KD treatment.
Related Concept Videos
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...
Cell Migration
Cell Migration
Cells Coordinate Growth and Proliferation
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists

